Aratana Therapeutics (PETX) – Analyst Ratings
-
Credit Suisse Downgrades Aratana Therapeutics (PETX) to Neutral
-
H.C. Wainwright Downgrades Aratana Therapeutics (PETX) to Neutral Following Acquisition
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PETX Stock Lookup